CureMetrix is committed to the advancement of technology that improves disease detection and survival rates worldwide. Their AI-based products and research leverage artificial intelligence and deep learning to develop next-generation medical image analysis technology that radiologists and patients can confidently rely on.

Their powerful image analysis platform currently serves as an adjunct precision tool for mammography. CureMetrix aims to equip radiologists with objective, data-driven answers to support patients and healthcare teams in making health decisions. The company believes that providing radiologists with advanced technology to support mammogram evaluations will lead to improved clinical outcomes, reduced healthcare costs, and increased assurance for patients receiving the highest standard of screening care.

Founded in 2014, CureMetrix has spent over 10 years developing highly effective products that are easy to install and operate within existing clinical workflows, minimizing extra steps for radiologists and patients. They have partnered with radiologists, cardiologists, and global institutions to collect over 5 million images to train and validate their algorithms. Their technology targets diseases such as breast cancer, heart disease, and kidney disease with the belief that AI can improve patient outcomes and extend the value of screening programs globally.

At CureMetrix, team members work on cutting-edge AI algorithms exploring medical images to detect cancer and other anomalies early and accurately. The company values diversity and encourages people with varied backgrounds to apply. They seek individuals passionate about discovery and being part of a team that changes lives.